דף הבית/מרכז התוכן/חדשות/Health & Medical Research
Health & Medical Research

Breakthrough PTSD treatment achieves 68% remission rate in clinical trial

ScienceDaily Health & Medicine
23 באוקטובר 2026
2 דקות קריאה
3 צפיות
Breakthrough PTSD treatment achieves 68% remission rate in clinical trial
זכויות היוצרים על התמונה שמורות לאתר המקור. התמונה מוצגת לשם תיאור הכתבה בלבד — ניתן לצפות בכתבה המלאה בקישור זה.

A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform PTSD care and pave the way for more precise treatments for other mental health conditions.

A newly FDA-cleared PTSD treatment uses personalized brain mapping and magnetic stimulation to target abnormal brain activity, with a clinical trial reporting a 52% reduction in symptoms and 68% remission. Researchers believe the technology could transform PTSD care and pave the way for more precise treatments for other mental health conditions.

מאמר מיובא

קרא את המאמר המלא באתר המקורי

תגיות:

#RSS
#ScienceDaily Health & Medicine

מאמרים נוספים

מHealth & Medical Research

A single brain signal may explain schizophrenia's most puzzling symptoms

A single brain signal may explain schizophrenia's most puzzling symptoms

Scientists have identified a weakened brain signal that may connect several seemingly unrelated symptoms of schizophrenia, including sensory processing difficulties, disorganized speech, and greater symptom severity. The surprising discovery could help explain the disorder's underlying mechanisms and potentially lead to earlier detection and new treatments.

29 באוקטובר 2026
2
Six popular sugar substitutes linked to faster brain aging

Six popular sugar substitutes linked to faster brain aging

A study of nearly 13,000 adults found that people consuming the most artificial sweeteners experienced a 62% faster decline in memory and thinking skills, equivalent to approximately 1.6 additional years of brain aging. Six popular sweeteners were linked to faster cognitive decline, raising concerns about the long-term brain health effects of common sugar substitutes, although causation was not established.

29 באוקטובר 2026
1
Less than 42 minutes of bright daylight linked to higher dementia risk

Less than 42 minutes of bright daylight linked to higher dementia risk

Getting more daylight could be linked to a surprisingly powerful benefit for brain health. In a study of more than 87,000 adults, researchers found that higher daytime light exposure was associated with a 16% lower risk of dementia, with longer exposure to bright light linked to even greater reductions. Remarkably, getting less than 42 minutes of bright daylight daily was a stronger predictor of dementia than six established risk factors.

29 באוקטובר 2026
1
Scientists discover that cranberry juice may help fight tooth decay

Scientists discover that cranberry juice may help fight tooth decay

Cranberry juice may offer an unexpected benefit beyond its reputation for helping prevent urinary tract infections: protecting teeth from decay. Researchers at the University of Illinois Chicago discovered that pure, unsweetened cranberry juice slowed the regrowth of dental plaque bacteria and reduced their production of acids that damage tooth enamel. The secret may lie in naturally occurring compounds called proanthocyanidins, which interfere with harmful bacteria.

29 באוקטובר 2026
0
Your blood pressure could be dangerous even when your numbers look normal

Your blood pressure could be dangerous even when your numbers look normal

Researchers have discovered a small group of brain cells that prevents dangerous blood pressure swings, even when average readings appear normal. The finding reveals a hidden source of cardiovascular risk and could open the door to new treatments that protect the heart and brain.

29 באוקטובר 2026
0

0 comments

Sign in to comment

Only registered users can add comments

No comments yet

Be the first to comment on this article

We value your privacy

We use necessary cookies to run MedNux, and with your consent cookies that measure traffic and show relevant ads. You can accept all, reject non-essential cookies, or choose by category. Read our Cookie Policy and Privacy Policy.